In Vitro & In Vivo Effect of Parathyroid Hormone Analogue (1-14) Containing α-amino-iso-butyric Acid Residue (Aib)1,3

다국어 초록 (Multilingual Abstract)

Firstly, parathyroid hormone (1-14) [PTH (1-14)] analogue containing various α-amino-iso-butyric acid residue (Aib) was synthesized by exchanging the 1st and 3rd Ala residues of alpha carbon of PTH (1-14). This analogue revealed to have the quite tight and stable α-helical structure using the nuclear magnetic resonance (NMR) analysis. The biological activities of these analogues were examined using a cAMP- generating assay in LLC-PK1 cell lines stably transfected with the wild- type human PTH1 receptor. Only the PTH analogue substituted with methyl moiety without acetylation showed significant cAMP generating action with 15.0±3.414 of EC50. Then, we used an ovariectomized rat model system to compare the in vivo effects of parathyroid hormone analogue with that of PTH (1-84). Daily subcutaneous administration of the unacetylated Aib1,3PTH (1-14) for 5 weeks in 30nM/kg subcutaneously with positive control group receiving PTH (1-84) with 8nM/ kg were performed. However, there was no significant change in spinal or femoral bone mineral density assessed by dual x-ray absorptiometry (DXA) in the Aib1,3PTH (1-14) group where definite increase of these parameters shown in the PTH (1-84) group (p<0.001). Assessment of bone strength was evaluated with no significant differences among all groups. It was quite disappointing to see the actual discrepancies between the result of significant pharmacokinetic potency and the in vivo clinical effect of the Aib1,3PTH (1-14). However, there are several limitations to mention, such as the short duration of treatment, matter of dosage, and insufficient effect of tight α-helical structures with absence of C-terminus. In conclusion, our findings suggest that unacetylated Aib1,3PTH (1-14) did not exhibit any anabolic effects at the bones of ovariectomized rats.

참고문헌 (Reference)

1 "prophylaxis and treatment of osteoporosis" 107-10, amjmed1991

2 "Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo" 19 : 469-477, 1996

3 "Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues" 43 : 690-699, 2004

4 "The extracellular amino-terminal region of the parathyroid hormone /PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-" 1 879-34 84, endocrinology1994

5 "The bioactive conformation of human parathyroid hormone. Structural evidence for the extended helix postulate" 122 : 3007-3014, 2000

6 "The (1-14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors" 13 : 670-680, 1999

7 "Structure and function of a minimal receptor activation domain of parathyroid hormone" 45 : 419-427, 2004

8 "Structural characteristics of alpha- helical peptide molecules containing Aib residues" 6747-56,

9 "NMR structure of a minimized human agouti related protein prepared by total chemical synthesis" 451 : 125-131, 1999

10 "Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor" 275 : 21836-21843, 2000

11 "Investigation of exchange processes by two-dimensional NMR spectroscopy" 4546-53,

12 "Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys" 16 : 157-165, 2001

13 "Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering" 479-85,

14 "Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice" 16 : 1665-1673, 2001

15 "Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues" 42 : 2282-2290, 2003

16 "Functional analysis of the PTH/ PTHrP network of ligands and receptors" 53 : 283-301, 1998

17 "Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits" 28 : 538-547, 2001

18 "Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis" 344 : 1434-1441, 2001

19 "Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry- dynamical simulated annealing calculations" 317-24,

20 "Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms Circumventing problems associated with folding" 129-36,

21 "Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints Application to crambin" 27-38,

22 "Determination of the three-dimensional solution structure of the antihypertensive and antiviral protein BDS-I from the sea anemone Anemonia sulcata" 2188-98,

23 "Crystallography & NMR system: A new software suite for macromolecular structure determination" 54 : 905-921, 1998

24 "Comparison of the abilities of human parathyroid hormone (hPTH)-(1-34) and [Leu27]-cyclo (Glu22-Lys26)-hPTH-(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats" 63 : 423-428, 1998

25 "Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice" 27 : 471-478, 2000

26 "Characterization of parathyroid hormone/receptor interactions: structure of the first extracellular loop" 39 : 8153-8160, 2000

27 "Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH (1-34)" 28 : 237-250, 2001

28 "Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats" 138 : 4330-4337, 1997

29 "Assignment of Complex 'H NMR Spectra via Two-Dimensional Homonuclear Hartmann- Hahn Spectroscopy" 2820-1,

30 "An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats" 12 : 384-392, 1997

31 "Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands" 38 : 13453-13460, 1999